Trials / Not Yet Recruiting
Not Yet RecruitingNCT07355478
Asia Myelodysplastic Syndrome (MDS) Registry
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide a contemporary view and offer invaluable insights into the demographic profiles, clinical characteristics, treatments, and real-world outcomes of individuals with myelodysplastic syndromes (MDS) in Asia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prescribed treatments for myelodysplastic syndromes (MDS) | According to the product label |
Timeline
- Start date
- 2026-03-26
- Primary completion
- 2026-10-31
- Completion
- 2027-09-30
- First posted
- 2026-01-21
- Last updated
- 2026-02-13
Locations
3 sites across 3 countries: Singapore, South Korea, Taiwan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07355478. Inclusion in this directory is not an endorsement.